V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310004559 | 310002005 | 1.58 | 47.5 | Palliative (P) | 2016-08-14 | 2016-08-14 | Liposomal Doxorubicin 40mg/m2 | N | N | 310020075 | CISPLATIN + FLUOROURACIL |
| 310004560 | 310006850 | 1.84 | 72.7 | Disease modification (D) | 2013-07-15 | 2013-07-17 | EOX | 2 | N | 310020076 | CAPECITABINE + OXALIPLATIN |
| 310004561 | 310002006 | null | null | Curative (C) | 2016-11-20 | 2016-12-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310020077 | CAPECITABINE + CISPLATIN |
| 310004562 | 310002007 | null | 81 | Palliative (P) | 2015-04-25 | 2015-04-30 | GEM-P | 99 | N | 310020079 | DACARBAZINE |
| 310004563 | 310002008 | null | null | null | 2017-08-10 | 2017-08-25 | Hydroxycarbamide | N | null | 310020083 | DACARBAZINE |
| 310004564 | 310002008 | 1.61 | 126.6 | Disease modification (D) | 2015-04-28 | 2015-04-29 | Liposomal Doxorubicin (Caelyx) | N | N | 310020083 | PACLITAXEL |
| 310004565 | 310009196 | 1.67 | 85.9 | Palliative (P) | 2014-03-04 | 2014-03-04 | Liposomal Doxorubicin 40mg/m2 | N | N | 310020085 | BCG |
| 310004566 | 310002009 | 1.75 | 47 | Palliative (P) | 2017-06-21 | 2017-06-21 | Capecitabine + Oxaliplatin 14day | N | null | 310020086 | VEMURAFENIB |
| 310004567 | 310002010 | 1.7 | 0 | Curative (C) | 2017-08-29 | 2017-08-30 | Hydroxycarbamide | N | N | 310020087 | CAPECITABINE + OXALIPLATIN |
| 310004568 | 310002011 | 1.68 | 69.4 | Neo-adjuvant (N) | 2016-10-01 | 2016-10-05 | CISPLATIN + FLUOROURACIL | 2 | N | 310020089 | CISPLATIN + ETOPOSIDE |
| 310004569 | 310006852 | null | 59.7 | Curative (C) | 2014-05-23 | 2014-05-23 | CHOEP - 21 days | N | N | 310020090 | CHOEP |
| 310004570 | 310006852 | 0 | 59.6 | Adjuvant (A) | 2015-07-23 | 2015-07-26 | GEM-P | N | N | 310020090 | CAPECITABINE + OXALIPLATIN |
| 310004571 | 310002012 | null | null | Adjuvant (A) | 2013-05-02 | 2013-05-12 | Liposomal Doxorubicin 50mg/m2 | null | Y | 310020095 | IMATINIB |
| 310004572 | 310002012 | 1.68 | -1 | Palliative (P) | null | 2015-12-30 | Rituximab | N | N | 310020095 | EOX |
| 310004573 | 310002012 | 1.6 | null | Curative (C) | 2019-03-24 | 2019-03-25 | EOX | N | null | 310020095 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004574 | 310002013 | 1.54 | 139 | Disease modification (D) | 2016-02-12 | 2016-02-12 | CISPLATIN + ETOPOSIDE | N | N | 310020099 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004575 | 310006854 | 1.79 | 57 | Disease modification (D) | 2017-01-16 | 2017-01-19 | Dacarbazine | Y | N | 310020101 | EOX |
| 310004579 | 310002015 | 1.79 | 85.9 | null | 2017-11-19 | 2017-11-25 | CHOEP | N | N | 310020106 | CHOEP |
| 310004580 | 310002016 | null | null | Adjuvant (A) | 2017-07-26 | 2017-08-01 | Mitomycin Intravesical | N | N | 310020107 | GEMCITABINE + PACLITAXEL |
| 310004581 | 310002017 | 1.59 | 71.4 | Disease modification (D) | 2013-02-10 | 2013-02-12 | Dacarbazine | 02 | null | 310020108 | OXALIPLATIN + MDG |
| 310004582 | 310006855 | null | null | Adjuvant (A) | 2018-04-10 | 2018-04-22 | Dacarbazine | null | null | 310020110 | ICON TRIAL |
| 310004583 | 310009200 | 1.54 | null | Adjuvant (A) | 2016-11-12 | 2016-11-20 | PACLITAXEL | 02 | N | 310020111 | RITUXIMAB |
| 310004584 | 310002018 | 1.5 | 43.6 | null | 2015-01-13 | 2015-01-16 | ECX | N | N | 310020113 | ECX |
| 310004585 | 310002019 | 1.56 | null | Adjuvant (A) | 2017-12-02 | 2017-12-03 | NB HRNBL-1 MOD N7 CAV | 02 | N | 310020115 | NOT MATCHED |
| 310004586 | 310006856 | 1.67 | 79.7 | Palliative (P) | 2017-04-17 | 2017-04-26 | Gemcitabine + Methylprednisolone | null | N | 310020118 | GEMCITABINE |
| 310004587 | 310009201 | 1.83 | 84 | Curative (C) | null | 2015-06-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310020119 | VEMURAFENIB |
| 310004588 | 310010417 | null | null | Curative (C) | 2013-06-04 | 2013-06-06 | Hydroxycarbamide | N | N | 310020121 | BEXAROTENE |
| 310004589 | 310011086 | 1.64 | 76 | Palliative (P) | null | 2015-11-08 | ECX | N | N | 310020122 | ECX |
| 310004590 | 310002020 | 1.73 | 81.5 | Palliative (P) | null | 2015-08-18 | Capecitabine + Cisplatin | N | N | 310020123 | EOX |
| 310004591 | 310006857 | 1.58 | null | Curative (C) | 2016-09-12 | 2016-09-20 | CHOEP - 14 days | N | null | 310020124 | CHOEP |
| 310004592 | 310002021 | null | 40.9 | Disease modification (D) | 2015-11-20 | 2016-05-28 | Dacarbazine | N | Y | 310020125 | EOX |
| 310004593 | 310006858 | null | 62.2 | null | null | 2016-07-06 | Liposomal Doxorubicin 50mg/m2 | N | N | 310020127 | BEXAROTENE |
| 310004594 | 310002022 | 1.57 | 93.6 | Palliative (P) | 2013-03-01 | 2013-03-12 | Hydroxycarbamide | 2 | null | 310020128 | OXALIPLATIN + MDG |
| 310004595 | 310006859 | 1.78 | 61.7 | Neo-adjuvant (N) | 2017-10-18 | 2017-10-19 | Liposomal Doxorubicin (Caelyx) | N | null | 310020129 | CAPECITABINE + OXALIPLATIN |
| 310004596 | 310002023 | 1.85 | 62.9 | Palliative (P) | 2013-03-08 | 2013-03-13 | ECX | 2 | N | 310020130 | ECX |
| 310004597 | 310002023 | 1.81 | 77 | Curative (C) | 2016-01-20 | 2016-01-29 | Capecitabine + Cisplatin | null | null | 310020130 | GEMCITABINE + PACLITAXEL |
| 310004598 | 310002024 | 1.76 | 9.2 | Neo-adjuvant (N) | 2015-11-03 | 2015-11-03 | Mitomycin Intravesical | Y | N | 310020134 | CISPLATIN + FLUOROURACIL |
| 310004599 | 310006861 | 1.64 | 82.6 | Palliative (P) | 2018-01-16 | 2018-02-05 | Capecitabine + Cisplatin | N | null | 310020137 | OXALIPLATIN + MDG |
| 310004600 | 310006861 | 1.79 | 89.4 | Neo-adjuvant (N) | 2015-08-26 | 2015-09-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 310020137 | MITOMYCIN INTRAVESICULAR |
| 310004601 | 310002025 | 1.7 | 62.4 | Curative (C) | 2013-10-19 | 2013-10-31 | Hydroxycarbamide | N | N | 310020139 | CAPECITABINE + CISPLATIN |
| 310004602 | 310002026 | 1.7 | 89.6 | Palliative (P) | 2015-12-29 | 2016-01-12 | ECX | N | N | 310020141 | ECX |
| 310004603 | 310002027 | 1.89 | 75.3 | Palliative (P) | 2015-08-11 | 2015-09-02 | IPILIMUMAB + NIVOLUMAB | N | N | 310020144 | IPILIMUMAB + NIVOLUMAB |
| 310004604 | 310002028 | 1.67 | 0 | Palliative (P) | 2017-12-22 | 2018-01-01 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310020148 | CAPECITABINE |
| 310004605 | 310006862 | 1.75 | 105 | Palliative (P) | 2016-01-14 | 2016-01-27 | Mitomycin Intravesical | 2 | N | 310020149 | MITOMYCIN INTRAVESICULAR |
| 310004606 | 310002029 | 1.82 | 79 | Neo-adjuvant (N) | 2016-04-05 | 2016-04-24 | Oxaliplatin + Modified de Gramont | N | N | 310020155 | MITOMYCIN INTRAVESICULAR |
| 310004607 | 310002030 | null | 82.1 | Disease modification (D) | 2015-02-03 | 2015-06-06 | Cisplatin +Fluorouracil (2 wk) | Y | N | 310020156 | EOX |
| 310004608 | 310002030 | 1.96 | 116.2 | Curative (C) | 2016-02-26 | 2016-03-06 | BEVACIZUMAB + CARBO + PACLITAXEL | null | N | 310020156 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 310004609 | 310009203 | 1.88 | 80.5 | Adjuvant (A) | 2016-04-03 | 2016-04-20 | CHOEP - 21 days | 02 | N | 310020159 | CHOEP |
| 310004610 | 310002031 | 1.62 | 62 | Palliative (P) | 2015-09-18 | 2015-09-19 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 310020161 | NOT MATCHED |
| 310004611 | 310002032 | 1.51 | null | Curative (C) | 2014-03-04 | 2014-03-06 | Liposomal Doxorubicin (Caelyx) | 2 | N | 310020162 | MITOMYCIN INTRAVESICULAR |